Concord Drugs ? manufacturing unit develops and manufactures pharmaceutical products for Concord and other customers, providing innovative drug optimization technologies, advanced manufacturing capabilities and global supply chain management services.Through an aggressive licensing and acquisition program, Concord is rapidly expanding in branded and specialty pharmaceuticals. With a rigorous focus on growth, Concord develops, manufactures and markets more than 200 prescription and over-the-counter pharmaceutical products.We are concentrating on the manufacturing and marketing of the following:
1. Injectibles a. sterile powder line, b. liquid parenterals - vials line and ampoules line.
2. Generic and speciality pharmaceuticals in tablet, capsule, and suppository dosage forms.
Concord?s product portfolio covers all major therapeutic areas, manufacturing and marketing prescription antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), anti-hypertensives, and ulcer/heartburn medications (H2 receptor antagonists) in capsule, table, powder & liquid injectibles and pediatric dosage forms.
Our speciality product is AMCRYLATE - Iso amyl 2-cyanoacrylate, a bio-ahesive - a wonder care for wound closure. AMCRYLATE is an advanced gamma sterilized, non-pigmented, non-toxic, non-allergic and bio-static tissue adhesive. It allows rapid wound closure with minimal scarring, reduces the risk of post-surgical infection and trauma, besides being simple and safe to use.